ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 641461 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 641461; 2) Community: the network communities that were significantly associated with the response to NSC 641461; 3) Molecule: the relationships between components within communities and NSC 641461; 4) MDR: the compounds that were significantly associated with the NSC 641461.

NSC Compound Enrichment Correlation
NSC 31709 Quinolinium, 2-[2-(2,5-dimethyl-1-pentyl-1H-pyrrol-3-yl)ethenyl]-1,6-dimethyl-, chloride 0.0273071169565318 0.018118133
NSC 351907 MASTOPARAN 0.0273071169565318 0.14042485
NSC 59220 [[5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3, 4-dihydroxyoxolan-2-yl]methoxy-ydroxyphosphoryl] [3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate, disodium salt 0.0273071169565318 0.13245455
NSC 610458 Camptothecin Derivative 0.0273071169565318 0.61238053
NSC 620277 4-N,N-bis-2'-cyanoethylaminobenzylidene-4-fluoro aniline 0.0273071169565318 -0.051918328
NSC 624659 ANTINEOPLASTIC-624659 0.0273071169565318 -0.0064515215
NSC 625505 Null 0.0273071169565318 0.048541117
NSC 627986 Null 0.0273071169565318 0.31429091
NSC 639174 Camptothecin Derivative 0.0273071169565318 0.67232279
NSC 639186 Raltitrexed 0.0273071169565318 0.25180123
Total:68  Current:37    [First] [Prev] [Next] [Last]